J Kortekaas


Affiliation: Wageningen University
Country: The Netherlands


  1. Kortekaas J, Kant J, Vloet R, Cêtre Sossah C, Marianneau P, Lacote S, et al. European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus. J Virol Methods. 2013;187:177-81 pubmed publisher
    ..More extensive validations with sera of known IgM status are, however, required to determine agreement between IgM ELISAs. ..
  2. Kortekaas J, de Boer S, Kant J, Vloet R, Antonis A, Moormann R. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. Vaccine. 2010;28:4394-401 pubmed publisher
    ..We also demonstrate that a single intramuscular vaccination of lambs, the main target species of RVFV, is sufficient to elicit a neutralizing antibody response. ..
  3. Oreshkova N, Spel L, Vloet R, Wichgers Schreur P, Moormann R, Boes M, et al. Preliminary Evaluation of a Bunyavirus Vector for Cancer Immunotherapy. J Virol. 2015;89:9124-7 pubmed publisher
    ..These results suggest that the NSR system holds promise for cancer immunotherapy. ..
  4. Kortekaas J, Oreshkova N, Cobos Jiménez V, Vloet R, Potgieter C, Moormann R. Creation of a nonspreading Rift Valley fever virus. J Virol. 2011;85:12622-30 pubmed publisher
    ..The methods reported here will greatly facilitate vaccine and drug development as well as fundamental studies on RVFV biology. Moreover, it may be possible to develop similar systems for other members of the bunyavirus family as well. ..
  5. Kortekaas J, Dekker A, de Boer S, Weerdmeester K, Vloet R, de Wit A, et al. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. Vaccine. 2010;28:2271-6 pubmed publisher
    ..The RVFV-neutralizing activity of the antisera from intramuscularly vaccinated calves was demonstrated, suggesting that NDV is a promising vaccine vector for the prevention of RVF in calves. ..
  6. Kortekaas J, Antonis A, Kant J, Vloet R, Vogel A, Oreshkova N, et al. Efficacy of three candidate Rift Valley fever vaccines in sheep. Vaccine. 2012;30:3423-9 pubmed publisher
    ..A single vaccination with each vaccine resulted in a neutralizing antibody response within three weeks after vaccination and protected lambs from viremia, pyrexia and mortality...
  7. Ramezanpour B, de Foucauld J, Kortekaas J. Emergency deployment of genetically engineered veterinary vaccines in Europe. Vaccine. 2016;34:3435-40 pubmed publisher
    ..The participants agreed that existing European regulations on the deliberate release of genetically engineered vaccines into the environment should be updated to facilitate quick deployment of these vaccines in emergency situations. ..